Big Take

Lynsey Addario’s life work means taking great risks to tell other people’s stories. She is a Pulitzer Prize winning war photographer who has been abducted twice while documenting conflicts from Afghanistan to Ukraine and Sudan.There aren’t many women in her field. In a new National Geographic documentary called “Love+War,” currently streaming on Disney+, she lets us into that world, one she’s made her profession for three decades. Addario shows how she adjusts from a work environment of grave danger and high-adrenaline to being a mother making the school run and spending time with her sons.In this conversation, she tells Mishal Husain, why she believes her job is to “bear witness” and how she came to it. She remembers the first time she used a camera and shares how her childhood prepared her to walk into any situation and connect with anyone, from soldiers to refugees and civilians living through extreme times.This interview contains descriptions of abduction, violence and sexual assault which some listeners/viewers may find distressing. 02:27 - Love+War03:34 - The turning point 06:00 - Learning about the risks07:00 “I don’t want to do this for a living”09:19 - Being held in Fallujah11:20 - On embed in Afghanistan 14:31 - Operation Rock Avalanche15:43 - Dealing with the emotion16:50 - The daughter of hairdressers in Connecticut17:44 - Getting her first camera19:30 - Planning a “shoot-list” 21:51 - Russian strike on Ukraine17:30 - Being held hostage in Libya31:02 - Survivor’s guilt33:30 Life at home36:30 - Social media and fake images 40:18 - Switching offWatch this podcast here: https://www.youtube.com/playlist?list=PLe4PRejZgr0Ns_wjGlmjlPz0cded0nTYS You can find the written version of this interview with Mishal’s notes on Bloomberg Weekend: https://www.bloomberg.com/latest/weekend-interviewSee omnystudio.com/listener for privacy information.

As AI-generated images ping pong around the internet, the Walt Disney Company has been mostly playing defense, using litigation to protect its intellectual property. But last week, Disney announced a $1 billion deal with OpenAI, licensing more than 200 of its iconic Disney characters for use on OpenAI’s video platform, Sora. On today’s Big Take podcast, host Sarah Holder talks with Bloomberg tech reporter Shirin Ghaffary and entertainment reporter Thomas Buckley about the terms of the deal, the opportunities and risks for each side and whether it might spur other similar partnerships. Read more: OpenAI Deal to License Disney Characters Is Entirely in Stock Hosted by: Sarah Holder; Produced by: Rachael Lewis-Krisky; Reported by: Shirin Ghaffary and Thomas Buckley; Edited by: Tracey Samuelson; Fact-checking by: Naomi Ng and Eleanor Harrison-Dengate. Engineering by: Katie McMurran. Senior Producer: Naomi Shavin. Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.See omnystudio.com/listener for privacy information.

The trucking industry has long been dominated by older white men. But as those truckers steer toward retirement, who will replace them? On today’s Big Take podcast, host Sarah Holder hits the road with Bloomberg’s Jaewon Kang, who’s been exploring how one company is trying to transform its trucking workforce. And we hear from MIT’s Chris Caplice, DAT Freight and Analytics’ Dean Croke and two Walmart truckers about what’s working for the industry and the challenges it faces on the road ahead. Read more: Walmart’s $115,000 Starting Pay and Better Rigs Draw Women to Trucking Hosted by Sarah Holder Produced by Julia Press Reported by Jaewon Kang Edited by Tracey Samuelson Fact-checking by Rachael Lewis-Krisky Engineering by Katie McMurran Senior Producer: Naomi Shavin Deputy Executive Producer: Julia Weaver Executive Producer: Nicole BeemsterboerSee omnystudio.com/listener for privacy information.

Treating cancer is a massive business. In 2024 alone, cancer treatments generated at least $200 billion in worldwide sales for the pharmaceutical industry, more than the obesity drug rush. But a Bloomberg News analysis showed that fewer than half of treatments reviewed — some of which have painful side effects — have been shown to extend patients’ lives. On today’s Big Take podcast, Bloomberg senior healthcare reporter Robert Langreth takes host David Gura inside what some doctors call the “cancer-industrial complex” — from the regulatory landscape that ushered in a wave of lucrative new drugs to the damaging financial and health impacts some treatments can have on patients. Read more: Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives. The Implants Were Supposed to Dissolve. They Didn’t. Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work Cancer Doctors Are Making a Fortune Off Drug-Trial Participants One Generic Cancer Drug Costs $35. Or $134. Or $13,000.See omnystudio.com/listener for privacy information.

The Philippines is no stranger to typhoons, but this year’s storms exposed something far uglier: a vast corruption scandal. On today’s Big Take Asia Podcast, host K. Oanh Ha speaks to Bloomberg’s Andreo Calonzo and Rosalind Mathieson about how billions of dollars earmarked for flood control vanished and what the crisis means for the country’s political and economic stability.See omnystudio.com/listener for privacy information.